University of Kentucky
Lexington, Kentucky, 40536, United States
NCT Number: NCT04002336
The current project is designed as phase 1 study conducted to improve/enhance normal voice. Fifteen Thirty non-treatment seeking individuals, with no identifiable vocal pathology on laryngeal examination, will be randomized to one of two groups; 1) Voice therapy delivery without App (control/standard of care), 2) Voice therapy delivery with app (experimental). Participants in both groups will attend weekly voice therapy sessions (for 6 weeks) with the PI and Co- I (Joseph Stemple). Control group participants will be provided with an audio file of the exercises, and an exercise log sheet to track progress. Experimental group participants will use the smartphone app, which allows participants to record home practice sessions in real time and upload sessions to the app server for the clinician to access and track. Three-wave surveys will be conducted at the baseline, four weeks and 6 weeks after the intervention. Other data sources include study administration, exercise logs, app data, and clinical assessment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lexington, Kentucky, 40536, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Traditional method of voice therapy
Other names: Vocal Function Exercises
Smartphone app, which allows participants to record home practice sessions in real time and upload sessions to the app server for the clinician to access and track.
Other names: Vocal Function Exercises
Time frame: 6 weeks
Number of completed home practice sessions
Time frame: 6 weeks
Maximum phonation time
Vrushali Angadi
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05158166
Adductor Spasmodic Dysphonia, Dysphonia
San Francisco, California, United States
View Trial DetailsNCT04584658
COVID-19, Coronaviridae Infections
Cambridge, United Kingdom
View Trial DetailsNCT03576365
Dysphonia, Functional Dysphonia
Maple Grove, Minnesota, United States
View Trial DetailsNCT06137131
Laryngeal Diseases, Nervous System Diseases
Ghent, East-Flanders, Belgium
View Trial Details